Heart pill showdown: one drug or two?
NCT ID NCT07313124
Summary
This study tested whether combining two cholesterol-lowering drugs works better and is as safe as using just one pill for people with heart disease. Researchers followed 66 adults with high cholesterol for 12 weeks, comparing a single drug (rosuvastatin) against a combination (rosuvastatin plus ezetimibe). They measured cholesterol levels and checked for side effects to see which approach was more effective and safer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beni-Suef University Hospital
Banī Suwayf, Beni Suweif Governorate, 62521, Egypt
Conditions
Explore the condition pages connected to this study.